Clinical Professor of Medicine, University Pennsylvania

Hematology

David Henry practices Hematology. He went to Perelman School of Medicine at the University of Pennsylvania. He received awards:"America's Top Doctors", "Philadelphia Magazine" and "America's Top Doctors for Cancer". David Henry has written publications. He has 32 publications published with PubMed. The lastest publication is: 'Bone Pain And Bone Targeting Agent (Bta) Treatment Pattern In Patients With Bone Metastases (Bms) From Prostate Cancer (Pc) In Real World Setting In Europe.'

Publications

---

• Bone Pain And Bone Targeting Agent (Bta) Treatment Patterns In Patients With Bone Metastases (Bms) From Breast Cancer (Bc) In Real World Setting In Europe.
• Bone Pain And Bone Targeting Agent (Bta) Treatment Pattern In Patients With Bone Metastases (Bms) From Prostate Cancer (Pc) In Real World Setting In Europe.
• Readmission rates due to Venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review.
• Reply to Araki et al.
• Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase ...
• Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials.
• Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from ...
• Thrombocytosis and Venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed...
• Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate ...
• Parenteral iron therapy in cancer-associated anemia.
• Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with che...
• High-molecular weight iron dextran: a wolf in sheep's clothing?
• Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?
• Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium.
• Increased importance of intraVenous iron in chemotherapy-induced anemia.
• IntraVenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.
• Epoetin alfa treatment for patients with chemotherapy-induced anemia.
• Blood management in total joint arthroplasty.
• The role of intraVenous iron in cancer-related anemia.
• Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
• Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: a randomized, double-blind, placebo-controlled trial.
• Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study.
• Autologous stem-cell transplantation can be performed safely without the use of blood-product support.
• Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future.
• Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group...
• Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
• The evolving role of epoetin alfa in cancer therapy.
• Guidelines for the use of epoetin in cancer patients: a much-needed step forward in standardizing anemia treatment.
• Preoperative use of recombinant human erythropoietin before total joint arthroplasty.
• Optimizing the treatment of anemia in cancer patients. The role of a new erythropoietic agent.
• Isolated Breast Metastases from Primary Gastric Adenocarcinoma.

Schools

---

• Creighton University

• Michael ReeseHumana

• Northwestern Meml Hospital

Procedures Preformed

---

• Vascular Duplex Ultrasonography and Plethysmography

Conditions Treated

---

• Abdominal Aortic Aneurysm (AAA)
• Acute Deep Vein Thrombosis (DVT)
• Acute Venous Embolism Thrombosis
• Atherosclerosis of Aorta
• View All

Doctors Specialties

---

• Interventional Radiology
• Neuroradiology
• Hematology

Accepted Insurances

---

Awards

---

• America's Top Doctors
• Philadelphia Magazine
• America's Top Doctors for Cancer

Education

---

• University of Pennsylvania Health System
• Perelman School of Medicine at the University of Pennsylvania

Hospital

---

• Pennsylvania Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Kathryn Bylow, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles H. Tiber, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert F. Taylor, MD This Doctor is OpenDoctor Recommended.
	Dr. Julie A. Panepinto, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mark C. Basham, MD
	Dr. David W. Litzau, MD This Doctor is OpenDoctor Recommended.
	Dr. John D. Lane, MD
	Dr. Eric Hohenwalter, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark W. Mewissen, MD This Doctor is OpenDoctor Recommended.
	Dr. Rowena C. Punzalan, MD This Doctor is OpenDoctor Recommended.
	Dr. James M. Walker, MD
	Dr. Karthikram Raghuram, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah B. White, MD
	Dr. Parameswaran Hari, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. John Ulmer, MD This Doctor is OpenDoctor Recommended.
	Dr. Shamsuddin Virani, MD This Doctor is OpenDoctor Recommended.
	Dr. Namrata M. Shah, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog